Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Blasi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Molecular Informatics|July 29, 2016
Ligand Efficiency Indices (LEIs): More than a Simple Efficiency YardstickCele Abad-Zapatero, Daniel Blasi
Bioorganic & Medicinal Chemistry|October 22, 2020
Optimization of kinetic stabilizers of tetrameric transthyretin: A prospective ligand efficiency-guided approachEllen Y Cotrina, Daniel Blasi, Marta Vilà, et al.
Molecular Informatics|July 29, 2016
Retrospective Mapping of SAR Data for TTR Protein in Chemico-Biological Space Using Ligand Efficiency Indices as a Guide to Drug Discovery StrategiesDaniel Blasi, Gemma Arsequell, Gregori Valencia, et al.
Journal of Medicinal Chemistry|October 24, 2013
Modulation of the fibrillogenesis inhibition properties of two transthyretin ligands by halogenationEllen Y Cotrina, Marta Pinto, Lluís Bosch, et al.
Journal of Medicinal Chemistry|June 8, 2017
Insights on the Interaction between Transthyretin and Aβ in Solution. A Saturation Transfer Difference (STD) NMR Analysis of the Role of IododiflunisalAna Gimeno, Luis M Santos, Mobina Alemi, et al.
Molecular Diversity|April 27, 2017
Synthesis, pharmacological evaluation and molecular docking of pyranopyrazole-linked 1,4-dihydropyridines as potent positive inotropesRakesh Kumar, Neha Yadav, Rodolfo Lavilla, et al.
European Journal of Medicinal Chemistry|September 23, 2021
Targeting transthyretin in Alzheimer's disease: Drug discovery of small-molecule chaperones as disease-modifying drug candidates for Alzheimer's diseaseEllen Y Cotrina, Luis Miguel Santos, Josep Rivas, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Molecular Informatics|July 29, 2016
Ligand Efficiency Indices (LEIs): More than a Simple Efficiency YardstickCele Abad-Zapatero, Daniel Blasi
Bioorganic & Medicinal Chemistry|October 22, 2020
Optimization of kinetic stabilizers of tetrameric transthyretin: A prospective ligand efficiency-guided approachEllen Y Cotrina, Daniel Blasi, Marta Vilà, et al.
Molecular Informatics|July 29, 2016
Retrospective Mapping of SAR Data for TTR Protein in Chemico-Biological Space Using Ligand Efficiency Indices as a Guide to Drug Discovery StrategiesDaniel Blasi, Gemma Arsequell, Gregori Valencia, et al.
Journal of Medicinal Chemistry|October 24, 2013
Modulation of the fibrillogenesis inhibition properties of two transthyretin ligands by halogenationEllen Y Cotrina, Marta Pinto, Lluís Bosch, et al.
Journal of Medicinal Chemistry|June 8, 2017
Insights on the Interaction between Transthyretin and Aβ in Solution. A Saturation Transfer Difference (STD) NMR Analysis of the Role of IododiflunisalAna Gimeno, Luis M Santos, Mobina Alemi, et al.
Molecular Diversity|April 27, 2017
Synthesis, pharmacological evaluation and molecular docking of pyranopyrazole-linked 1,4-dihydropyridines as potent positive inotropesRakesh Kumar, Neha Yadav, Rodolfo Lavilla, et al.
European Journal of Medicinal Chemistry|September 23, 2021
Targeting transthyretin in Alzheimer's disease: Drug discovery of small-molecule chaperones as disease-modifying drug candidates for Alzheimer's diseaseEllen Y Cotrina, Luis Miguel Santos, Josep Rivas, et al.
Pageof 1